June 9, 2025
Intangible Assets

Pharmalittle: We’re reading about FDA scrambling for workers, Pfizer CEO pay and more

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is, so far, rather modest. We plan to promenade with the official mascots, catch up on our reading and look in on the

Read More
Intangible Assets

Federal Circuit Provides Guidance on What Claims Can Properly Serve As Obviousness-Type Double Patenting References

In a precedential decision issued on August 13, 2024, the U.S. Court of Appeals for the Federal Circuit held that a first-filed, first-issued, later-expiring claim cannot be invalidated by a later-filed, later-issued, earlier-expiring reference claim having a common priority date.1 Obviousness-Type Double Patenting Obviousness-type double patenting (ODP) is a judicially created doctrine dating back to

Read More